Ethanol induced adaptations in 5-HT2c receptor signaling in the bed nucleus of the stria terminalis: Implications for anxiety during ethanol withdrawal by Marcinkiewcz, Catherine A. et al.
Ethanol induced adaptations in 5-HT2c receptor signaling in the 
bed nucleus of stria terminalis: Implications for anxiety during 
ethanol withdrawal
Catherine A. Marcinkiewcz, Cayce E. Dorrier, Alberto J. Lopez, and Thomas L. Kash
Bowles Center for Alcohol Studies, University of North Carolina at Chapel Hill, Chapel Hill, North 
Carolina, 27599
Abstract
One of the hallmarks of alcohol dependence is the presence of a withdrawal syndrome during 
abstinence, which manifests as physical craving for alcohol accompanied by subjective feelings of 
anxiety. Using a model of chronic intermittent ethanol (CIE) vapor in mice, we investigated the 
role of serotonin2c signaling in the BNST as a neural substrate underlying ethanol-induced anxiety 
during withdrawal. Mice were subjected to a 5-day CIE regimen of 16 hours of ethanol vapor 
exposure followed by an 8 hour “withdrawal” period between exposures. After the 5th and final 
exposure, mice were withdrawn for 24 hours or 1 week before experiments began. Anxiety-like 
behavior was assessed in the social approach, light dark, and open field test with mice showing 
deficits in social, but not general anxiety-like behavior that was alleviated by pretreatment with the 
5HT2c-R antagonist SB 242,084 (3 mg/kg, i.p.) 24 hours and 1 week post-CIE. Using 
immunohistochemistry and whole cell patch clamp electrophysiology, we also found that CIE 
increased FOS-IR and enhanced neuronal excitability in the ventral BNST (vBNST) 24 hrs into 
withdrawal in a 5HT2c-R dependent manner. This enhanced excitability persisted for 1 week post-
CIE. We also found that mCPP, a 5HT2c/b agonist, induced a more robust depolarization in cells 
of the vBNST in CIE mice, confirming that 5HT2c-R signaling is upregulated in the vBNST 
following CIE. Taken together, these results suggest that CIE upregulates 5HT2c-R signaling in 
the vBNST, leading to increased excitability. This enhanced excitability of the vBNST may drive 
increased anxiety-like behavior during ethanol withdrawal.
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1. Introduction
Chronic alcohol use can induce persistent changes in circuit function in the brain (Kash et 
al., 2006, Holmes et al., 2012), which may contribute to subjective feelings of stress and 
anxiety during alcohol withdrawal. The impact of anxiety on the developmental course of 
alcoholism has been well-documented in the literature and is especially prominent in Type II 
alcoholics, who use alcohol as a means of mitigating anxiety symptoms (Lesch and Walter, 
1996; Bleich et al., 2004; Kiefer, 2005; Leggio et al., 2009). In preclinical studies of chronic 
ethanol exposure anxiety-like behaviors have been observed in a variety of behavioral 
paradigms, including the elevated plus maze, the open field, and the light-dark test (see 
Kliethermes 2005 for review). Recently, the social interaction test was utilized as an index 
of anxiety-like behavior in rats during chronic ethanol withdrawal, and this behavior was 
found to depend in part on serotonin receptor signaling in the limbic system (Overstreet et 
al., 2003; Knapp et al., 2004; Overstreet et al., 2006).
Alcohol dependence is associated with alterations in serotonin (5HT) systems in the brain, 
including increased expression of tryptophan hydroxylase (TPH) in the dorsal raphe (DR) 
and 5HT transporter (5HTT) binding sites in the amgydala and the paraventricular nucleus 
of the hypothalamus (PVN), which may contribute to anxiety-like states (Bonkale et al., 
2006; Storvik et al., 2008). In particular, there is ample evidence to suggest that serotonin 
type 2 receptors (5HT2-Rs) may play a critical role in anxiety states arising from chronic 
stress and ethanol withdrawal in alcohol dependence disorders (Lal et al., 1993; Krystal et 
al., 1994). The 5HT2-R family includes 3 subtypes; 5HT2a, 2b and 2c, all of which are 
present in varying degrees in the brain (Roth et al., 1998). Our focus is on the 5HT2c 
receptor (5HT2c-R), a seven transmembrane G-protein coupled receptor (GPCR) that is 
distributed through the limbic system, where it modulates release of other neurotransmitters 
such as GABA and dopamine (Di Matteo et al., 2001). Activation of the 5HT2c-R is thought 
to contribute to the anxious features of several SSRI antidepressants (Ni and Miledi, 1997), 
whereas antagonism of these receptors may actually relieve dysphoria via disinhibition of 
dopamine signaling (Dremencov et al., 2005). In preclinical studies, mouse strains with a 
low anxiety phenotype tend to have reduced 5HT2c-R functionality resulting from post-
transcriptional editing relative to other more anxiety-prone mouse strains (Englander et al., 
2005). Indeed, anxiety is strongly associated with 5HT2c-R levels in the brain, as 
overexpression tends to increase anxiety (Kimura et al., 2009), whereas deletion of the 
5HT2c receptor (5HT2c-R KO) results in a low anxiety phenotype relative to wild-type mice 
(Heisler et al, 2007). These findings are supported by pharmacological studies in rodents, 
which demonstrate that inhibitors of central 5HT2c-R function have anxiolytic effects 
(Wood et al., 2001), whereas 5HT2-R agonists (i.e. mCPP) potentiate anxiety in the social 
approach test (Mongeau et al., 2010).
Anxiety is a significant contributing factor to the negative reinforcing properties of ethanol 
during withdrawal, which was previously shown to be depending on 5HT2c-R signaling 
(Overstreet et al., 2003; Knapp et al., 2004; Overstreet et al., 2006). Both peripheral 
injection of 5HT2c-R antagonists and site-specific injection of 5HT2c-R inverse agonists 
into the central amygdala can mitigate withdrawal-induced anxiety, suggesting a potential 
site of action for the anxiogenic effects of 5HT2c-R signaling. Additional studies 
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demonstrate that FOS immunoreactivity (FOS-IR) in response to an anxiogenic stimulus is 
reduced in both the central amygdala (CeA) and bed nucleus of stria terminalis (BNST) of 
5HT2c-R knockout mice (Heisler et al., 2007), which implicates both structures in the 
pathophysiology of anxiety. The BNST is both highly interconnected with and functionally 
analogous to the CeA, and it’s particular role in anxiogenic states associated with 
withdrawal and relapse has been extensively characterized in the literature (Aston-Jones & 
Harris, 2004; Huang et al., 2010; Silberman et al., 2013). The BNST contains a high density 
of both 5HT2c-Rs (Pompeiano et al., 1994; Wright et al., 1995), which mediate excitatory 
postsynaptic effects in the anterolateral aspect (Guo et al, 2009), a region heavily populated 
with GABAergic and CRF neurons. The 5HT2c/b agonist mCPP also induces FOS-IR in the 
BNST, which is suggestive of increased neuronal activation (Singewald et al., 2003). 
Together, these data support a role for 5HT2c-Rs in the BNST in anxiogenesis.
The ethanol vapor inhalation model has been used to achieve ethanol intoxication in mice 
over a 14–16 hour period with blood ethanol concentrations stabilizing at 150–200 mg/dl 
(Melendez et al., 2012; Lopez et al., 2012; Kroener et al., 2012). Delivered in this fashion, 
CIE has been shown to elicit robust changes in physiology in the BNST (Kash et al., 2009; 
Szücs et al., 2012), the hippocampus (Roberto et al., 2002), the basolateral amygdala (Läck 
et al., 2007), the central amygdala (Roberto et al., 2006) and the mPFC (Holmes et al., 2012; 
Kroener et al., 2012). In this study, the ethanol vapor inhalation model was used to establish 
a pattern of chronic ethanol exposure, which is predicted to induce an anxious phenotype in 
DBA/2J mice. The goal of the present study was to investigate the hypothesis that 
withdrawal from chronic intermittent ethanol (CIE) exposure induces hyperactivity in the 
BNST via upregulation of 5HT2c-R signaling, which in turn precipitates anxiety. Using 
combined behavioral, immunohistochemical, and electrophysiological approaches, we 
assess activation and neuronal excitability in the vBNST.
2. Methods
2.1 Animals
Male DBA/2J mice were obtained from Jackson laboratories at 6 weeks of age and allowed 
to acclimate to the animal facility at the UNC Thurston-Bowles Center for 1 week with ad 
libitum access to food and water before experiments began.
2.2 Drugs
All drugs used in electrophysiological experiments (TTX, mCPP, RS 102221) were 
purchased from Tocris (Bristol, UK). TTX, and mCPP were dissolved in ddH2O at a stock 
concentration of 5 mM and 50 mM, respectively, and stored at −20°C. RS 102221 was 
dissolved to 100 mM in DMSO and stored at −20°C. On the day of the experiment, drugs 
were diluted to their final concentrations in normal aCSF. For behavioral and 
immunohistochemical experiments, SB 242,084 was purchased from Caymen Chemical 
(Ann Arbor, Michigan), suspended in 0.5% carboxymethylcellulose vehicle at a working 
concentration of 0.3 mg/ml, then injected at 3 mg/kg. This dose was chosen primarily based 
on results from Breese and colleagues indicating that pretreatment with 3 mg/kg SB 242,084 
reduced withdrawal-induced anxiety in rats in the social interaction test (Overstreet et al., 
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2003) and voluntary ethanol consumption following withdrawal (Overstreet et al., 2007). 
This highly selective 5HT2c-R antagonist exhibits 158-fold selectivity over 5HT2a receptors 
and 100-fold selectivity over 5HT1b receptors. There is some evidence that SB 242,084 has 
locomotor activating effects that follow an inverted U shaped curve peaking at 1 mg/kg, but 
are not present at 3 mg/kg (Martin et al., 2002). Our use of the 3 mg/kg dose circumvents 
this potential confound.
2.3 Chronic Intermittent Ethanol (CIE)
The ethanol inhalation system used in our laboratory was designed by La Jolla Alcohol 
Research, Inc. (La Jolla, CA) to house mice in a controlled air flow chamber with 
dimensions of 27.5 cm length × 17 cm width × 13 cm height. Male mice between 7–9 weeks 
old were given daily injections of the alcohol dehydrogenase inhibitor pyrazole (1 mmol/kg, 
i.p.) 30 minutes before ethanol exposure to stabilize blood ethanol concentration (BEC). 
Volatilized ethanol (95%) was generated by bubbling air through an air stone submerged in 
95% ethanol solution at a flow rate sufficient to generate BECs in the range of 150–200 
mg/dl in adult male mice. Pyrazole-treated mice were exposed to air (controls) or ethanol 
vapor for 16 hours per day for 5 days. All biochemical, electrophysiological and behavioral 
manipulations were carried out 24 hrs or 1 week after the end of the last exposure. This 
experimental design allowed us to probe the behavioral and physiological effects of acute 
and protracted withdrawal from CIE. The 24-hour time point was chosen to give the mice 
sufficient time to fully metabolize the ethanol but still capture the acute effects of ethanol 
withdrawal, such as handling induced convulsions (Metten and Crabbe, 2005). The 1 week 
time point was chosen to probe for persistent changes in function. In a subset of the 
behavioral studies, mice were injected with 3 mg/kg SB 242,084 or vehicle 1 hour prior to 
testing in the social approach test. For immunohistochemical studies, mice were injected 4 
hours after removal from the chambers and then 3 hours before perfusion.
2.4 Electrophysiology
Mice were decapitated under isofluorane anesthesia 24 hours or 7 days after the last ethanol 
exposure. Brains were rapidly removed and immediately placed in a solution of ice-cold 
sucrose-artificial cerebrospinal fluid (aCSF) [(in mM): 194 sucrose, 20 NaCl, 4.4 KCl, 2 
CaCl2, 1 MgCl2, 1.2 NaH2PO4, 10 glucose, and 26 NaHCO3 saturated with 95% O2/5% 
CO2. Brains were sectioned at 0.07 (mm/s) on a Leica 1200S vibratome to obtain 300 μm 
coronal slices of the BNST, which were incubated in a heated holding chamber containing 
normal, oxygenated aCSF [(in mM):124 NaCl, 4.4 KCl, 2 CaCl2, 1.2 MgSO4, 1 NaH2PO4, 
10.0 glucose, and 26.0 NaHCO3] maintained at 30 ± 1°C for at least 1 hour before 
recording.
Slices were transferred to a recording chamber (Warner Instruments) submerged in normal, 
oxygenated aCSF maintained at 28–30°C at a flow rate of 2 ml/min. Neurons of the BNST 
were visualized using infrared-differential interference contrast (DIC) video-enhanced 
microscopy (Olympus). Slices were bathed in normal aCSF for at least 30 minutes before 
performing whole-cell patch clamp experiments. Borosilicate electrodes pulled with a 
Flaming-Brown micropipette puller (Sutter Instruments) with a pipette resistance between 
3–6 MΩ filled with internal solution [(in mM): 135 KCl-gluconate, 5 NaCl, 2 MgCl2, 10 
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HEPES, 0.6 EGTA, 4 ATP, and 0.4 GTP, pH= 7.35, 290 mOsmol] were used to patch cells 
in the BNST.
Signals were acquired using a Multiclamp 700B amplifier and analyzed with Clampfit 10.3 
software (Molecular Devices, Sunnyvale, CA, USA). All experiments were conducted in 
current clamp mode with the holding current set to zero. For excitability experiments, a 
current ramp protocol was used to determine the current required to induce firing (rheobase) 
and the voltage at first spike. The number of spikes generated by discrete current steps was 
also determined using a 10 pA current step protocol from 0 to 150 pA (V-I plot). In a subset 
of experiments, the 5HT2c-R antagonist RS 102221 (10 μM) was bath applied for 10 
minutes before rheobase and VI plots were performed.
In another set of experiments, the effects of the 5HT2-R agonist mCPP on neuronal 
excitability were determined by changes in membrane potential. Tetrodotoxin (TTX, 500 
nM) was included in the bath to prevent firing of action potentials and to allow accurate 
determination of changes in membrane potential. Following establishment of a stable 
baseline for at least 4 minutes, mCPP (20 μM) was bath applied for 10 minutes.
The ability of mCPP to depolarize cells was calculated by subtracting baseline membrane 
potential from the average membrane potential over the last 2 minutes of drug application. 
Only cells with a stable access resistance (less than a 20% change from baseline to the end 
of the experiment) were used in the data analysis.
In order to calculate membrane conductance, a 25 pA current-step protocol from −75 to 50 
pA was used to generate a V-I plot, from which the slope could be computed. The 
membrane conductance is equal to the inverse slope (1/slope) and the change in conductance 
was calculated by subtracting baseline conductance from the conductance after 10 min of 
mCPP application. For analysis of spike amplitude and half-width, we used data generated 
from the V-I plot. For each cell, these measures were taken at the minimum current injection 
necessary to induce at least 5 consecutive action potentials. The fast AHP was determined 
by measuring the minimum Vm during the 7 ms time window after the onset of the action 
potential in a 7 ms time window after action-potential onset (Senn et al., 2014).
2.5 Behavior
Social approach test—Male DBA/2J mice were tested in the social approach test 24 hr 
or 1 week after the last exposure to CIE and 1 hour after injection with SB 242,084 or 
vehicle. The testing apparatus consisted of a 3-chambered Plexiglass container, each 20 cm 
L × 40.5 cm W × 22 cm H, divided by 2 panels with a small opening at the base to allow 
movement between the chambers (Moy et al., 2008). At the start of each testing session, the 
test mouse is placed in the center chamber and was subsequently allowed to move freely 
between the 3 chambers. Infrared photocell beams at the base of the openings between 
compartments detected movement across chambers, and the number of entries and time 
spent in each chamber was automatically recorded by analysis software. During the 
habituation phase of the test, mice were allowed to freely explore all three empty chambers 
for a period of 10 minutes. At the end of the habituation phase, the mouse was placed back 
in the center chamber with the doors closed. A stainless steel holding cage (11 cm high × 
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10.5 in diameter) was placed in the center of the two outermost chambers. A “stranger” 
mouse was then placed inside the holding cage on one side (e.g. the right), while the other 
cage remained empty. During the 10-minute “sociability” phase, the doors were opened and 
the test mouse was again allowed to freely explore the chambers; however, this time, the 
time spent sniffing the stranger mouse or the empty cage was recorded manually. Relative 
levels of anxiety between-groups were determined by the time spent sniffing the stranger 
mouse during the sociability phase, with less time sniffing the stranger mouse reflecting 
increased anxiety-like behavior. In the final or “novelty” phase, a second stranger mouse 
was placed inside of the previously empty cage. The time spent by the test mouse sniffing 
each stranger mouse was recorded manually over the 10-minute session.
Light-dark test—Male DBA/2J mice were habituated to the procedure room for at least 2 
hours prior to testing, which took place 24 hours into CIE withdrawal. Phototaxic 
exploration was evaluated in photocell-equipped automated open field chambers with dark 
zone inserts that divide the chamber in half (Chamber: 40 cm × 40 cm × 30 cm; L/D Insert: 
20 × 40 × 30 cm). The testing apparatus is divided between a bright chamber and a neutral 
dark chamber. Mice were placed into the Dark Zone and allowed to freely roam for 15 
minutes, given a choice between staying in the dark side of the chamber and entering the 
lighted side. The chamber was cleaned with 70% EtOH prior to each testing session. 
Behavior was scored using the Versamax system, Accuscan Instruments. Total time (sec) 
spent in either the Light Zone was used as a measure of anxiety-like behavior and number of 
entries into the Light Zone as a measure of locomotor activity.
Open field test—Mice that were 24 hrs into CIE withdrawal were injected with SB 
242,084 (3 mg/kg) or vehicle 1 hour before testing in the open field. Briefly, the open field 
arena (50 cm × 50 cm × 25 cm) was divided into the center, defined as the central 25% of 
the arena, and the periphery using EthoVison XT 7 (Noldus Information Technologies, 
Wageningen, The Netherlands). Mice were placed individually in the left front corner of the 
arena and were allowed to explore the environment for 20 min. The time spent in the center 
of the box, average velocity, and velocities while moving were scored using EthoVision XT 
7.
2.6 Immunohistochemistry
Mice were perfused transcardially using 30 ml phosphate buffered saline (PBS) followed by 
30 ml 4% paraformaldehyde in PBS. Brains were dissected out and postfixed for 24 hours in 
4% paraformaldehyde at 4°C, t hen transferred to 30% sucrose until fully saturated. Slices of 
the BNST (45 μm) were prepared on a Leica 1200S vibratome and stored in 50/50 
glycerol/PBS at −20°C for FOS i mmunohistochemistry. Slices were first washed in PBS, 
then incubated in 50% methanol and followed by 3% H2O2. Slices were washed in PBS 
again followed by a 24 hour incubation at 4°C in 0.5% BSA, 0.3% Triton-X100, and c-fos 
antibody (1:3000; Santa-Cruz). The next day, slices were washed in Tris-HCl, NaCl, Tween 
(TNT) buffer, incubated in Tris, NaCl blocking (TNB) buffer, and then incubated in goat 
anti-rabbit HRP-linked IgG (1:200) in TNB buffer for 30 minutes. Slices were washed in 
TNT, and tyramine signal amplification (TSA) with Cy3 was performed using a kit (Perkin 
Elmer).
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Slices were mounted with Vectashield on glass slices and imaged using a Zeiss AXIO Zoom 
V16 microscope with ZEN pro 2012 software. FOS-positive cells from at least 3 sections 
per animal were counted using NIH image software separately in the dorsolateral BNST 
(dlBNST), dorsomedial BNST (dmBNST) and vBNST.
2.7 Statistical analysis
Two-way analysis of variance (ANOVA) or Student’s t-tests was used to analyzed 
behavioral and immunohistochemical data. A two-way ANOVA was also used to analyze 
rheobase, voltage of first spike, resting membrane potential, spike amplitude and spike half-
width data in our electrophysiology experiments, and a 3-way ANOVA was used to analyze 
V-I plots. Changes in membrane potential and membrane conductance induced by mCPP 
were analyzed using Student t-tests.
3. Results
3.1 CIE-induced disruption of social approach is mitigated by 5HT2c-R antagonists
Withdrawal from a chronic ethanol diet was previously shown to elicit a behavioral 
phenotype in rats that approximates anxiety using the social interaction test that is mitigated 
by pretreatment with 5HT2c-R antagonists (Overstreet et al., 2003; Knapp et al., 2004; 
Overstreet et al., 2006). In order to replicate these findings in mice, we exposed 39 male 
DBA/2J mice to air or CIE vapor for 5 days and then evaluated the impact of the 5HT2c-R 
antagonist SB 242,084 (3 mg/kg) on anxiety-like behavior in the social approach test 24 
hours into withdrawal. A two-way ANOVA revealed that SB 242,084 significantly 
attenuated the effects of CIE on social approach test (Figure 1A). We found a significant 
main effect of drug (F(1,35)=7.773, p<0.01) and a significant CIE × drug interaction F(1,35) 
= 8.576, p<0.01). The main effect of CIE was not significant (F(1,35)=3.055, p>0.05); 
however, Bonferroni post-hoc comparisons did reveal a significant difference between air- 
and CIE-exposed mice in the vehicle-treated group only (t=3.263, p<0.001). There was also 
a significant effect of drug in the CIE exposed group only (t=4.098, p<0.001). These results 
demonstrate that CIE induces an anxiety-like phenotype in mice that is partly mediated by 
5HT2c-R signaling.
Previous reports regarding the locomotor activating effects of SB 242,084 suggest that this 
drug may be enhancing social approach by way of increasing locomotor activity (Martin et 
al, 2002). In order to address this, locomotor activity as measured by the number of 
crossings between chambers was also significantly impacted by ethanol (F(1,35)=11.87, 
p<0.01), but not by SB 242,084 (F(1,35)=1.03, p>0.05) and no significant interaction 
between the two (F(1,35)=1.438, p>0.05) (Figure 1B). The fact that SB 242,084 was able to 
rescue deficits in social approach but not locomotor activity suggests that these are 
dissociable features of CIE withdrawal. These findings are in agreement with those 
previously reported by Breese and colleagues (Overstreet et al., 2003; Knapp et al., 2004).
We also evaluated behavior in the light-dark test to determine if CIE effects on social 
approach are generalizable to other tests of anxiety-like behavior. We found a trend toward a 
reduction in time spent in the light that was non-significant (Figure 1C; t=2.004, df=16, 
p>0.05) in a group of 18 mice. However, there was also a significant reduction in number of 
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entries into the light zone (Figure 1D; t=2.50, df=15, p<0.05), which could reflect an 
increase in anxiety-like behavior. However, the light-dark test does not allow us to 
distinguish anxiogenic from locomotor effects, so this decrease in light zone entries may 
also reflect a CIE induced locomotor deficit in this particular assay.
Finally, we measured performance in the open field test as another measure of general 
anxiety. Surprisingly, we found that center time was attenuated in the CIE group treated 
with SB 242,084, suggesting that 5HT2c-R blockade has anxiogenic effects after CIE in this 
particular assay ((F1,26)=12.17, p<0.01 for main effect of CIE, F(1,26)=0.085, p>0.05 for 
main effect of SB 242,084 and F(1,26)=4.701, p<0.05 for CIE × SB 242,084 interaction) 
(Figure 1E). Posthoc comparisons were only significant between the SB 242,084 treated air 
and CIE-exposed animals (t=3.873, p<0.01). These results indicate that anxiety-like 
behavior in the social approach test is dissociable from the general anxiety-like behavior 
observed in the open field test, and that these two forms of anxiety-like behavior are 
differentially modulated by 5HT2c-R signaling.
Locomotor activity in the open field was also assessed using total distance travelled as a 
representative measure (Figure 1F). As in the social approach test, there was a main effect of 
CIE (F(1,26)=38.10, p<0.001) that was not modified by SB 242,084 (F(1,26)=2.166, 
p>0.05), and SB 242,084 did not have any effect on its own (F(1,26)=0.024, p>0.05). These 
results indicate that CIE can induce hypolocomotion in the open field test through some 
mechanism that does not involve 5HT2c-R signaling.
3.2 CIE increases FOS-IR in the vBNST in a 5HT2c-R dependent manner
Once we had established a role for 5HT2c-R signaling in CIE induced disruption in behavior 
in mice, we were interested in identifying a neural mechanism and locus of action. Based on 
the fact that anxiogenic stimuli elicit an increase in FOS-IR in the BNST, which is 
attenuated in 5HT2c-R knockout mice, we postulated that the BNST was an important 
neural substrate mediating anxiety after stress and potentially ethanol withdrawal. This 
hypothesis is also supported by the fact that peripheral injection with the anxiogenic drug 
mCPP was shown to increase FOS-IR in the BNST, indicating that 5HT2c-Rs have 
excitatory effects in the BNST. In order to test this hypothesis, male DBA/2J mice (n=39) 
were exposed to air or CIE and then injected with the 5HT2c-R antagonist, SB 242,084 or 
vehicle at 4 and 22 hours post withdrawal. At the 24 hour time point, the mice were perfused 
and FOS immunohistochemistry was performed to assess CIE effects on neuronal activity in 
the BNST. In a two-way ANOVA, CIE was found to increase FOS-IR in the ventral portion 
of the BNST (vBNST), an effect that was attenuated by pretreatment with 5HT2c-R 
antagonists (Figure 2A–E). We found a significant CIE × drug interaction (F(1,35)=12.81, 
p<0.01) and a significant main effect of drug (F(1,35)=5.769, p<0.05). Bonferroni post-tests 
revealed significant increases in FOS-IR in vehicle-treated CIE animals relative to vehicle-
treated controls (t=3.937, p<0.001) and relative to drug-treated CIE animals (t=4.15, 
p<0.001). No other comparisons were significant. These results confirm that withdrawal 
from CIE activates neurons in the vBNST in a 5HT2c-R dependent manner.
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This effect appears to be restricted to the ventral portion of the BNST, as there were no 
significant differences in FOS+ cell counts in either the dorsolateral or dorsomedial aspects 
(Figure 2F–G).
3.3 CIE enhances neuronal excitability in the vBNST
Having found that CIE leads to an increase in FOS-IR in the BNST, we next sought to 
determine if there were any alterations in neuronal function. In particular, we expected that 
CIE would increase excitability of neurons in the vBNST in a 5HT2c-R-dependent fashion; 
consistent with the fact that mCPP was previously found to depolarize neurons in the BNST 
(Guo et al., 2009). Whole cell patch clamp electrophysiology was used to measure 
excitability in the vBNST following CIE exposure. The rheobase (Figure 3A–B), the voltage 
at first spike (Figure 3C), and the resting membrane potential (RMP) (Figure 3D) were used 
as a measure of basal excitability. These data were collected from 8 control/aCSF cells, 7 
control/RS 102221 cells, 9 CIE/aCSF and 9 CIE/RS 102221 cells. Our results indicate a 
significant main effect of CIE (F(1,29)=6.94, p<0.05), but no effect of RS 102221 
(F(1,29)=1.664×10−7, p>0.05) and no significant CIE × RS 102221 interaction (F(1,29)=.
417, p>0.05) on rheobase. These data suggest that although CIE reduces the rheobase (and 
hence increased membrane excitability), this effect is not 5HT2c-R dependent. The voltage 
at first spike was not significantly affected by CIE or RS 102221, as revealed by a two-way 
ANOVA (F(1,29)=0.018, p>0.05 for main effect of CIE, F(1,29)=.8841, p>0.05 for main 
effect of RS 102221, and F(1,29)=0.3511, p>0.05 for CIE × RS 102221 interaction). On 
RMP, a two-way ANOVA revealed a significant main effect of CIE (F(1,29) = 6.197, 
p<0.05), but not RS 102221 (F(1,29)=1.202, p>0.05) and no CIE × RS 102221 interaction 
(F(1,29)=2.788, p>0.05). Input resistance was also measured; however, there was no 
significant difference between the groups (Data not shown).
Next we looked at the number of action potentials generated over a range of current 
injections (VI plot) as a measure of inducible excitability (Figure 3E–F). In these 
experiments, we pooled data from 8 control/aCSF cells, 7 control/RS 102221 cells, 5 CIE/
aCSF and 10 CIE/RS 102221 cells. No more than 2 cells were used per mouse. vBNST 
neurons in CIE mice fired significantly more action potentials during current stimulation, 
relative to air controls, and this effect was absent in the presence of RS102221 (RS102221 × 
CIE × stimulation interaction: F(20,520)=6.13, p<0.001), suggesting that vBNST neurons 
can be induced to fire more action potentials following CIE, and that this effect is likely 
mediated by an upregulation of 5HT2c-R signaling. Activation of 5HT2c-Rs is associated 
with inhibition of G-protein coupled potassium channels (GIRKs), which may account for 
the increased spiking frequency observed in these experiments. Interestingly, we also 
observed a trend toward a decrease in spike half-width (Figure 3G) that did not reach 
significance but did appear to be modified by RS 102221. Given that inhibition of K+ 
channels would be expected to increase spike half width (Vincent et al., 2000), these data 
suggest that other channels contribute to this effect of 5HT2c-Rs on spike half width. We 
also analyzed fast AHP (Figure 3H) and found no significant differences between groups 
(F(1,21)=0.04, p>0.05 for main effect CIE, F(1,21)=0.02, p>0.05 for main effect RS 102221 
and F(1,21)=0.189, p>0.05 for CIE × RS 102221 interaction).
Marcinkiewcz et al. Page 9
Neuropharmacology. Author manuscript; available in PMC 2016 February 01.
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
3.4 CIE augments 5HT2c-R signaling in the vBNST
Given the fact that enhanced excitability in the vBNST post-CIE appears to be mediated by 
5HT2c-R signaling, we hypothesized that the 5HT2c/b-R agonist would elicit a greater 
excitatory response in the vBNST of CIE-relative to air-exposed mice. Although mCPP is 
nonselective for the 5HT2c receptor, it displays a preference for 5HT2c and 2b receptors 
(pEC50 = 7.09 and 7.2, respectively) over 5HT2a (pEC50 = 6.65 and 5HT1a receptors 
(pEC50 = 5.9). Given that 5HT2b receptors are not highly expressed in the BNST, we 
treated mCPP as a preferential 5HT2c-R agonist. Previously, mCPP has been reported to 
depolarize neurons in the BNST (Guo et al., 2009), the lateral amygdala (Yamamoto et al., 
2014) and in hypothalamic nuclei (Qiu et al, 2007; Sohn et al., 2011; Roepke et al., 2012). 
Chronic ethanol exposure, by way of increased 5HT2c-R signaling, would be expected to 
augment this response to mCPP. Consistent with this, our results indicate that bath 
application of mCPP to neurons of the vBNST depolarized the membrane potential (MP) by 
an average of 2.07 ± 1.53 mV in control (n=9 cells) and 6.67 ± 1.32 mV in CIE mice (n=7 
cells) (Figures 4A–B). T-tests comparing the change in MP induced by mCPP (delta or Δ 
MP) between control and CIE groups were statistically significant (t(14)=2.19, p<0.05).
3.5 CIE induces persistent alterations in behavior and neural function in the vBNST
In order to evaluate if there were persistent changes in anxiety-like behavior and physiology 
following CIE withdrawal, another cohort of mice were exposed to the social approach test 1 
week after removal from the ethanol chambers. Again, mice were injected with 3 mg/ml SB 
242,084 1 hour before testing. Our results indicate a significant main effect of CIE 
(F(1,36)=9.097, p<0.01) and a significant interaction between CIE and SB 242,084 
(F(1,36)=9.573, p<0.01), indicating that CIE increases anxiety like behavior 1 week post-
CIE in a 5HT2C-R dependent fashion (Figure 5A). Bonferroni posttests comparing vehicle-
treated control and CIE mice were also significant (t=4.321, p<0.001), as were post-tests 
comparing vehicle-treated and SB 242,084-treated CIE mice (t=3.389, p<0.01).
We also assessed persistent changes in excitability in the vBNST after 1 week of withdrawal 
from CIE, since this is proposed to be the mechanism underlying elevations in anxiety. 
Although we found no changes in rheobase (Figure 5B) or voltage at first spike (Figure 5C) 
between controls and CIE-treated mice, there was a significant increase in spiking frequency 
as a function of current (Figure 5D). We pooled data from 5 control cells and 5 CIE cells 
(one cell in the control group was excluded as an outlier after performing a Grubb’s test). A 
two-way repeated measures ANOVA revealed a significant main effect of CIE 
(F(1,160)=9.969, p<0.05), a significant main effect of current (F(20,160)=15.78, p<0.001), 
and a significant interaction between CIE and current (F(20,160)=6.556. p<0.001). 
Bonferroni post-tests were performed to make pairwise comparisons between control and 
CIE mice at different current injections and we found significant differences starting at 120 
pA (t=3.519, p<0.05) and continuing through the final 200 pA (t=5.093, p<0.001). Taken 
together, these data suggest that CIE can induce persistent changes in behavior which may 
be attributed to enhanced excitability in the vBNST.
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4. Discussion
Acute ethanol acts to stimulate 5HT release in discrete brain regions known to be involved 
in affect regulation including the ventral hippocampus (Bare et al., 1998; Kheirbek and Hen, 
2011) and nucleus accumbens (Yoshimoto et al., 1991). Withdrawal, on the other hand, 
appears to cause 5HT depletion in the hippocampus (Kempf et al., 1990), the mPFC and the 
amygdala (Carlson and Drew, 2006). Given that 5HT2c-Rs are enriched in these areas 
(Pompeiano et al., 1994; Eberle-Wang et al., 1997; Liu et al., 2007; Kheirbek and Hen, 
2011), it stands to reason that repeated cycles of ethanol exposure and withdrawal may 
induce long-lasting neuroadaptations in 5HT2c-R systems by way of dysregulated 5HT 
signaling (Pandey and Pandey, 1996). These, in turn, may contribute to anxiety during 
ethanol withdrawal. Here we present evidence that withdrawal from chronic ethanol disrupts 
social approach behavior which is attenuated by pretreatment with 5HT2c-R antagonists. To 
our knowledge, this is the first study documenting effects of ethanol withdrawal on social 
approach behaviors in mice, although previous reports have established this in rats 
(Overstreet et al., 2003; Knapp et al., 2004; Overstreet et al., 2006). Previous studies have 
failed to detect anxiety in C6 or D2 mouse strains after a 72 hr exposure to ethanol vapor 
(Finn et al., 2000), although it should be noted that these mice were tested during peak 
withdrawal (5.5–9.5 hr after removal from the chambers), which may not have been 
sufficient time for ethanol to be completely metabolized. Our mice were tested 24 hrs and 1 
week after a 5-day CIE exposure. These behavioral outcomes of CIE were associated with 
an increase in neuronal activation and excitability in the vBNST, suggesting 
hyperexcitability in the vBNST as a potential mechanism for the anxiety-promoting effects 
of chronic ethanol. This hyperexcitability was attenuated by 5HT2c-R blockade, indicating 
that CIE may augment 5HT2c-R signaling in the vBNST. Further evidence comes from the 
fact that following CIE exposure, neurons in the vBNST exhibit a greater depolarization in 
response to mCPP. In sum, these data indicate that chronic ethanol promotes anxiety-like 
behavior by enhancing 5HT2c-R signaling in the vBNST, an important neural output to 
brainstem and hypothalamic nuclei that control behavioral and neuroendocrine responses to 
stress.
4.1 CIE withdrawal disrupts social approach via 5HT2c-R signaling
Withdrawal from chronic ethanol exposure engages neural circuits in the brain that are 
associated with stress, such that repeated episodes of withdrawal can be conceptualized as a 
chronic stressor. Anxiety states brought on by stress are accompanied by dysregulation of 
5HT2c-R signaling in regions of the extended amygdala including the basolateral amygdala 
(BLA) (Christianson et al., 2010; Li et al., 2012), the CeA (Hackler et al., 2007; Overstreet 
et al., 2006), and the BNST (Heisler et al., 2007). Given the similarities between stress and 
ethanol withdrawal, we predicted that CIE would induce anxiety in mice in a 5HT2c-R 
dependent fashion, and this was confirmed by a decrease in social approach 24 hours after 
withdrawal from CIE that was mitigated by pretreatment with 3 mg/kg SB 242,084. The 
utility of 5HT2c-R antagonists in alleviating deficits in social behaviors during ethanol 
withdrawal has been previously validated in rats (Overstreet et al., 2003; Knapp et al., 2004; 
Overstreet et al., 2006), while other studies have shown that the anxiogenic actions of 
certain antidepressants can be blocked by 5HT2c-R antagonists (Bagdy et al., 2001). 
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Conversely, 5HT2c-R agonists such as mCPP or MK-212 produce subjective feelings of 
anxiety and cravings for alcohol in human alcoholics (Krystal et al., 1994). Together, these 
data implicate brain 5HT2c-R systems in the withdrawal-induced anxiety and suggest new 
avenues for pharmacotherapy in treating alcohol dependence.
The 5HT2c-R antagonist SB 242,084 has been previously reported to increase locomotor 
activity in rats at 1 mg/kg, but not 3 mg/kg, the dose used in this study (Martin et al., 2002). 
Nevertheless, we examined locomotor activity in the social approach test and the open field 
test and found that CIE-induced hypoactivity was not rescued by SB 242,084, indicating that 
the apparent anxiolytic actions of SB 242,084 are not driven by locomotor deficits.
Contrary to our expectations, there was no change in anxiety in the open field in the vehicle 
treated CIE group, but the SB 242,084 treated CIE group exhibited a decrease in center time, 
indicative of anxiety-like behavior. This implies that SB 242,084 actually increases more 
generalized anxiety as measured by the open field test during CIE withdrawal and that this 
anxiety is dissociable from specific type of social anxiety determined by the social approach 
test. These opposing effects of 5HT2c-R antagonism on these two aspects of anxiety may 
indicate that they are governed by divergent neural circuits. To illustrate this point, a recent 
study found that optogenetic Gq/5HT2c-R activation of GABAergic interneurons in the DR 
5HT2c-Rs actually relieve anxiety in the open field (Spoida et al., 2014), while another 
study by Breese and colleagues found that a 5HT2c-R inverse agonist (SB 243,213) 
microinjected into the DR had no effect on CIE induced anxiety in the social interaction test 
(Overstreet et al., 2006). However, intra-amygdalar injections of SB 243,213 did relieve CIE 
induced deficits in social interaction, suggesting that 5HT2c-R signaling in the amygdala 
can modulate the social aspects of anxiety. Taken together, these studies suggest that 
5HT2c-R signaling can reduce generalized anxiety via activation of negative feedback 
circuits in the DR that inhibit firing of 5HT neurons, while social anxiety is actually 
increased by 5HT2c-R signaling in the extended amygdala. Our data supports this 
hypothesis by demonstrating a differential effect of 5HT2c-R antagonists on anxiety in the 
social approach test and the open field test.
4.2 CIE increases cfos expression in the vBNST in a 5HT2c-R dependent fashion
The BNST has reciprocal connections with the dorsal raphe nucleus (DRN) and is 
particularly sensitive to the effects of drugs selective for 5HT1a, 2a, 2c, and 5HT7 receptors 
(Guo et al., 2009). Previous studies have shown that 5HT2c-R agonists and anxiogenic 
stimuli increase FOS-IR in the BNST (Heisler et al., 2007; Singewald et al., 2003), so we 
anticipated that ethanol withdrawal, as a chronic stressor, would do the same. Our results 
indicate that FOS-IR is upregulated in the ventral BNST (vBNST) following CIE exposure, 
and this was attenuated by peripheral injection of a 5HT2c-R antagonist during withdrawal. 
Interestingly, swim stress also elicits an increase in FOS-IR in the vBNST (Briand et al., 
2010), suggesting that ethanol withdrawal and stress engage similar neural circuits, and 
likely elicit similar behaviors. These results are in agreement with previous studies showing 
that ethanol withdrawal induces cfos expression in other brain regions associated with 
anxiety in rats (Bonassoli et al., 2011). Overall, these data suggest that CIE can elicit 
changes in neuronal activity in the vBNST which may contribute to anxiety-like behavior, 
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and that this behavioral plasticity involves upregulation of 5HT2c-R signaling. While it 
seems likely that CIE activates vBNST neurons directly via increases in local 5HT2c-R 
signaling, we did not directly confirm expression of 5HT2c-Rs in these cells, leaving open 
the possibility that CIE alters FOS levels indirectly via 5HT2c-R dependent adaptations in 
inputs to the vBNST. However, in light of our electrophysiological data showing enhanced 
mCPP response in vBNST neurons, we think a direct modulation of FOS-IR is extremely 
probable.
Surprisingly, these ethanol induced adaptations in neuronal activation were limited to the 
vBNST, as we found no changes in FOS-IR in either the dmBNST or dlBNST. These results 
may reflect their divergent roles in modulating network function within the BNST and their 
efferent projections to brain regions that govern fear and anxiety-related behavior. The 
dorsal aspect of the BNST, which encompasses the dlBNST and dmBNST, is primarily 
comprised of GABAergic interneurons which receive dense amygdalar inputs and maintain 
feedforward inhibition over BNST output neurons, a large population of which resides in the 
vBNST. These neurons innervate a variety of structures involved in emotional behavior, 
including the central amygdala (CeA), lateral hypothalamus (LH), PVN, ventrolateral 
periaquaductal grey (vlPAG) and ventral tegmental area (VTA) (Dong et al., 2001; Dong 
and Swanson, 2004). Our results suggest that vBNST neurons may be uniquely sensitive to 
the effects of repeated ethanol exposure, inducing both short-term and long-term adaptations 
in circuits that regulate emotional expression. Importantly, we cannot exclude that these 
changes in c-fos in the vBNST are due to circuit effects.
4.3 CIE induces hyperexcitability in the vBNST via upregulation of 5HT2c-R signaling
Our electrophysiology results demonstrate that CIE increases membrane excitability in the 
vBNST on three separate measures; rheobase, RMP and spiking frequency as a function of 
current. However, only the effect on current induced spiking is 5HT2c-R dependent, 
suggesting that ethanol induced adaptations in other systems account for the alterations in 
rheobase and RMP. In the presence of TTX, mCPP was able to evoke a greater increase in 
membrane potential in the vBNST of CIE mice, indicating that 5HT2c-R signaling within 
recorded neurons in the vBNST was enhanced after CIE withdrawal. We postulate that 
ethanol-induced hyperexcitability in the vBNST via enhancement of 5HT2c-R signaling 
promotes anxiety-like behavior during ethanol withdrawal (Figure 6).
While an in depth analysis of intracellular signaling mechanisms elicited by activation of 
5HT2c-Rs is beyond the scope of this paper, we did notice that CIE reduced the spike 
duration in a 5HT2c-R dependent manner, although this effect was non-significant. This is 
consistent with a 5HT2c-R elicited increase in Ca2+ entry via opening of TRPC channels 
(Sohn et al., 2011; Yamamoto et al., 2014).
4.4 CIE induces persistent alterations in behavior and neural function in the vBNST
Having established that acute CIE withdrawal can elicit robust deficits in behavior that are 
attributable to altered 5HT2cR signaling in the vBNST, we next sought to determine if these 
changes persist during protracted withdrawal. Our data suggest that deficits in social 
approach are still present 1 week after withdrawal from CIE and are mitigated by 
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pretreatment with a 5HT2c-R antagonist, suggesting that alterations in 5HT2c-R function 
are a contributing factor. Next we analyzed the effects of CIE on neural excitability in the 
vBNST, which confirmed the presence of a persistent change in spiking frequency as a 
function of current. In sum, these data provide further evidence that CIE can induce long-
lasting plasticity in behavior and neural function, particularly in the vBNST. However, as 
we did not examine if these later changes were sensitive to 5HT2c-R antagonism, it is 
possible that there are alternate systems that are engaged at this timepoint.
4.5 The vBNST as critical node of interaction between 5HT and stress pathways in the 
brain
The results of this study highlight the potential significance of the vBNST as a neural 
interface between serotonin and stress processing centers in the brain. Serotonergic neurons 
from the DRN (Shin et al., 2008; Phelix et al., 1992) heavily innervate the BNST and 
preferentially form synapses within the vBNST, which sends outputs to other brain regions 
involved in emotional processing. The importance of these functional connections is 
emphasized by the fact that human alcoholics exhibit increased connectivity between the 
amygdala and BNST during abstinence (O’Daly et al., 2012). The BNST projection to the 
VTA, but not the LH, also plays a prominent role in stress-induced reinstatement of reward-
related behaviors in animal models of addiction (Briand et al., 2010; Sartor and Aston-Jones, 
2012), presumably by engaging VTA dopamine neurons (Georges and Aston-Jones, 2001; 
2002). Given the functional parallels between stress and ethanol withdrawal, it is likely that 
CIE withdrawal also engages this neurocircuitry. Repeated cycles of CIE have been shown 
to promote increased drinking (Griffin et al., 2009), indicating that repeated withdrawal acts 
in a similar manner to stress in the facilitation of reward-seeking behavior. Interestingly, this 
vBNST-to-VTA pathway is appetitive and anxiolytic if GABAergic neurons are involved, 
whereas glutamatergic projections appear to be aversive and anxiogenic (Jennings et al., 
2013). These opposing effects on behavior could potentially explain the seemingly 
contradictory emotional states experienced during ethanol withdrawal, namely anxiety and 
anhedonia coupled with an increased motivational drive to seek out ethanol. Given that our 
model of CIE withdrawal is both anxiogenic and increases excitability within the vBNST, it 
would be interesting to parse out the effects of CIE on glutamatergic vs GABAergic neurons 
within the vBNST that project to the VTA in a future study.
5. Conclusion
Repeated cycles of ethanol exposure and withdrawal can elicit specific changes in 5HT2c-R 
signaling that confer hyperexcitability in the ventral BNST, an important neural relay to 
emotion processing centers of the brain that orchestrate behavioral responses to stress and 
other stimuli. These findings indicate that 5HT2c-Rs in the vBNST may be an important 
neural substrate underlying a specific type of anxiety during ethanol withdrawal that may 
precipitate relapse, and that blocking this receptor may alleviate some of the symptoms of 
alcohol withdrawal.
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Highlights
• Chronic intermittent ethanol (CIE) induces social but not general anxiety-like 
behavior
• Ethanol-induced social anxiety is disrupted by pretreatment with 5HT2c-R 
antagonists
• CIE excites neurons in the ventral BNST in a 5HT2c-R dependent fashion
• CIE increases sensitivity of vBNST neurons to 5HT2c-R agonists
• CIE-induced adaptations in behavior and physiology persist for 1 week
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Figure 1. CIE-induced anxiety like behavior in the social interaction test is mitigated by 5HT2c-
R antagonists
Social, but not general anxiety-like behavior in the social approach test is mitigated by 
5HT2c-R antagonists. Pretreatment with SB 242,084 normalizes CIE induced anxiety-like 
behavior (A) but does not rescue hypolocomotion in the social approach test (B). CIE effects 
on time spent in the light (C) and light entries (D) in the light-dark test. SB 242,084 induces 
an anxiety-like phenotype in the open field test in CIE exposed mice (E) but does not induce 
locomotor deficits nor rescue CIE induced locomotor deficits (F)
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Figure 2. 
CIE enhances FOS-IR in the ventral BNST in a 5HT2c-R dependent fashion. FOS-IR in (A) 
vehicle-injected control (air exposed) mice, (B) SB-242,084-injected control mice, (C) 
vehicle-injected CIE mice, and (D) SB-242084-injected CIE mice. Graphical representation 
of FOS cell counts in the (E) ventral, (F) dorsolateral and (G) dorsomedial BNST for all 
groups
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Figure 3. 
Neuronal excitability in the vBNST increases 24 hours after CIE in a 5HT2c-R dependent 
fashion. Representative traces of voltage ramp used to determine rheobase (A), the average 
rheobase (B), the average voltage at first spike (C), and the average RMP (D). 
Representative traces from control and CIE cells of the current step protocol used to 
determine VI plot (E) and the average VI plot across all groups (F). The average spike width 
(G) and the average AHP amplitude (H) across all groups
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Figure 4. 
CIE augments 5HT2c-R signaling in the vBNST. The average trace of a neuron in the 
vBNST during application of mCPP (20 μM) (A) and a graphical representation of the 
average change in membrane potential by mCPP (B)
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Figure 5. Persistent adaptations in 5HT2c-R sensitive behavior and physiology at 1 week post-
CIE
Ethanol-induced adaptations in behavior and physiology persist 1 week after withdrawal 
from CIE. CIE induced deficits in social approach persist 1 week after withdrawal and are 
mitigated by 5HT2c-R antagonists (A). Excitability measures 1 week after CIE exposure 
including rheobase (B), voltage at first spike (C), and spiking frequency as a function of 
current (D).
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Figure 6. 
Circuit model of ethanol-induced plasticity in the vBNST. 5HT depolarizes neurons in the 
vBNST via 5HT2c-Rs. Following CIE, neurons in the vBNST become more excitable due to 
an upregulation in 5HT2c-R signaling (shown here as an increase in 5HT2c-R surface 
expression, but could also be due to altered 5HT2c-R editing), more efficient 5HT2c-R-
Gαq/11 coupling, etc., leading to increased anxiety-like behavior.
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